Health
Chemical biomarker could be used to better manage treatments for COVID-19 – News-Medical.Net
Varying severity of COVID-19 symptoms in patients is reflected by levels of a chemical biomarker in their body which scientists say could be used to better manage…
Varying severity of COVID-19 symptoms in patients is reflected by levels of a chemical biomarker in their body which scientists say could be used to better manage treatments and other interventions, including vaccinations.
In a new paper in International Journal of Infectious Diseases, medical experts in Italy and Australia examined levels of a chemical called serum amyloid A (SAA), a protein synthesised in the liver which can spike up to 1,000-fold within the first 24-48 hours of an infection.
…
-
Noosa News15 hours agoTully Sugar Mill celebrates 100 years of cane harvesting amid floods and cyclones
-
Noosa News13 hours agoFlatmates of missing teen Pheobe Bishop, 17, identified
-
General18 hours agoOne person dead after house fire in Melbourne’s south-east
-
General12 hours agoPostecoglou’s message touches Blues AFL coach Voss after Spurs’ Europa League win